Lilburn, GA, United States of America

Sanjay Srivatsan

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 20.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Sanjay Srivatsan

Introduction

Sanjay Srivatsan is a notable inventor based in Lilburn, GA (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines and treatments for viral infections. With a total of 3 patents to his name, his work is recognized for its potential impact on public health.

Latest Patents

Sanjay's latest patents focus on Prefusion RSV F proteins and their use. These patents disclose Respiratory Syncytial Virus (RSV) antigens, including a recombinant RSV F protein that is stabilized in a prefusion conformation. The patents also cover nucleic acids encoding these antigens and methods for producing them. Furthermore, methods for generating an immune response in a subject are disclosed. In some embodiments, the method aims to treat or prevent an RSV infection in a subject by administering a therapeutically effective amount of the antigen.

Career Highlights

Sanjay Srivatsan is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution allows him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Sanjay has worked alongside notable colleagues such as Barney S Graham and Jason Scott McLellan. These collaborations have further enhanced the quality and impact of his research.

Conclusion

Sanjay Srivatsan's innovative work in the field of medical research, particularly in developing treatments for RSV, showcases his dedication to improving public health. His contributions through patents and collaborations highlight the importance of scientific research in combating viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…